ramosetron has been researched along with Emesis in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 17 (51.52) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, JS; An, HJ; Kang, JH; Kim, GM; Kim, HJ; Kim, JY; Koo, DH; Kwon, JH; Lee, H; Lee, YG; Park, KU; Seol, YM; Sohn, J; Song, H; Yang, JH; Yun, HJ | 1 |
| Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y | 1 |
| Aizawa, F; Chuma, M; Goda, M; Hamano, H; Ishizawa, K; Izawa-Ishizawa, Y; Kanda, M; Murai, Y; Niimura, T; Okada, N; Yagi, K; Yoshida, A; Yoshioka, T; Zamami, Y | 1 |
| Ando, T; Ikeoka, T; Imaizumi, M; Kawakami, A; Ueki, I; Usa, T | 1 |
| Bae, DS; Choi, CH; Kim, BG; Kim, HJ; Kim, MK; Kim, TJ; Lee, JW; Lee, YY; Park, JY; Yoon, A | 1 |
| Akashi, K; Arita, S; Ariyama, H; Baba, E; Komoda, M; Kumagai, H; Kusaba, H; Nagata, K; Nakano, M; Okumura, Y; Takaishi, S; Tamura, S; Uchida, M | 1 |
| Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Jeong, S; Kang, G; Ki, MS; Kim, JK; Kim, KR; Shim, HJ | 1 |
| Ahn, JS; Cho, YH; Jang, JS; Kang, JH; Kim, HJ; Kim, JS; Kim, SW; Kim, SY; Kim, YS; Ko, YH; Lee, HW; Lee, NR; Lee, SN; Lee, SR; Park, KU; Shin, SW; Song, EK; Yun, HJ | 1 |
| Bae, WK; Cho, SH; Choi, K; Chung, IJ; Hwang, JE; Jeong, SW; Kang, G; Kim, HN; Kim, JK; Kim, KR; Lee, J; Shim, HJ; Shin, HY | 1 |
| Seo, HJ; Son, H; Song, HJ | 1 |
| Bang, YJ; Chie, EK; Ha, SW; Im, SA; Jang, JY; Kim, K; Kim, SW; Kim, TY; Oh, DY | 1 |
| Ayuhara, H; Okuyama, K; Ozeki, T; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Chao, TY; Ho, CL; Hsieh, RK; Lin, ZZ; Su, WC | 1 |
| Rabasseda, X | 1 |
| Liu, DW; Liu, YY; Shan, XJ; Xie, XD; Zheng, ZD | 1 |
| Chan, V; Villalon, A | 1 |
| Higuchi, K; Koizumi, W; Nagaba, S; Nakayama, N; Nonaka, M; Saigenji, K; Tanabe, S; Yago, K | 1 |
| Liu, YP; Shi, J; Teng, YE; Zhang, JD | 1 |
| Eamtang, S; Pantusart, A; Pautad, N; Saereesongkhun, C; Srisomboon, J; Suprasert, P; Sutthichat, A; Tantipalakorn, C; Thienthong, H | 1 |
| Hamada, J; Kai, Y; Kochi, M; Kuratsu, J; Makino, K; Morioka, M; Nakamura, H; Yano, S | 1 |
| Sriuranpong, V; Voravud, N | 1 |
| Ai, B; Dong, M; Han, X; He, X; Huang, D; Liu, P; Shi, Y; Yang, S; Zhang, C; Zhou, S | 1 |
| Hashimoto, R; Ikeda, K; Kurokawa, N; Okamoto, Y; Takagi, T; Takenaka, M; Ueda, T; Uejima, E | 1 |
| Iwase, O; Okuyama, K; Ozeki, T; Yamada, Y; Yoshimoto, K | 1 |
| Ito, H; Kamato, T; Miyata, K; Nagakura, Y; Nishida, A; Yamano, M; Yuki, H | 1 |
| Furuya, T; Kurihara, H; Miyata, K; Ohta, M; Suzuki, T; Tokunaga, T; Yanagisawa, I | 1 |
| Tsukagoshi, S | 1 |
| Hojo, S; Noguchi, S; Shiba, E; Taguchi, T; Takamura, Y; Tsukamoto, F; Watanabe, T; Yoneda, K | 1 |
| Akutagawa, N; Ishioka, S; Ito, E; Kiya, T; Kudo, R; Sagae, S; Saito, T; Sugimura, M; Umemura, K | 1 |
| Fujii, Y; Kobayashi, N; Saitoh, Y | 1 |
| Chen, Y; Liu, YF; Shen, Y; Shen, ZX; Wang, AH; Zeng, XY | 1 |
| Feng, F; He, Y; Zhang, P | 1 |
| Honda, K; Ito, H; Kamato, T; Miyata, K; Yamano, M; Yuki, H | 1 |
3 review(s) available for ramosetron and Emesis
| Article | Year |
|---|---|
Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
Topics: Antiemetics; Antineoplastic Agents; Benzimidazoles; Humans; Nausea; Randomized Controlled Trials as Topic; Serotonin Antagonists; Treatment Outcome; Vomiting | 2016 |
Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.
Topics: Animals; Antiemetics; Benzimidazoles; Child; Humans; Nausea; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Vomiting | 2002 |
[A new antiemetic ramosetron hydrochloride].
Topics: Animals; Antiemetics; Antineoplastic Agents; Benzimidazoles; Granisetron; Guinea Pigs; Humans; Male; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1997 |
19 trial(s) available for ramosetron and Emesis
| Article | Year |
|---|---|
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Palonosetron; Prognosis; Prospective Studies; Quality of Life; Surveys and Questionnaires; Vomiting; Young Adult | 2020 |
Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Carboplatin; Dexamethasone; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Morpholines; Nausea; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Vomiting; Young Adult | 2014 |
A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting.
Topics: Antineoplastic Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Treatment Outcome; Vomiting | 2015 |
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
Topics: Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Ondansetron; Prospective Studies; Single-Blind Method; Treatment Outcome; Vomiting | 2015 |
Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients.
Topics: Aged; Antiemetics; Antineoplastic Agents; Asian People; ATP Binding Cassette Transporter, Subfamily B; Benzimidazoles; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Receptors, Serotonin, 5-HT3; Vomiting | 2017 |
A randomized, double-blind, parallel, comparative study to evaluate the efficacy and safety of ramosetron plus dexamethasone injection for the prevention of acute chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Dexamethasone; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Vomiting | 2010 |
[Effects of Nasea on prevention of gastrointestinal side effects caused by chemotherapeutic drugs].
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Agents; Benzimidazoles; Female; Gastrointestinal Diseases; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Time Factors; Treatment Outcome; Vomiting | 2003 |
Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Time Factors; Treatment Outcome; Vomiting | 2004 |
A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Cross-Over Studies; Double-Blind Method; Endpoint Determination; Esophageal Neoplasms; Female; Granisetron; Humans; Male; Middle Aged; Patient Satisfaction; Vomiting | 2003 |
[Preventive effects of ramosetron and granisetron in prevention of gastrointestinal reaction associated with chemotherapeutic agents: a comparative study].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Appetite; Benzimidazoles; Cisplatin; Doxorubicin; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Vomiting | 2003 |
Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Injections, Intravenous; Middle Aged; Patient Satisfaction; Probability; Risk Factors; Severity of Illness Index; Treatment Outcome; Vomiting | 2004 |
Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy.
Topics: Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Brain Neoplasms; Female; Glioma; Granisetron; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Vomiting | 2005 |
Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Benzimidazoles; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Vomiting | 2005 |
Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: A prospective randomized controlled study.
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Vomiting | 2007 |
[Usefulness of ramosetron hydrochloride on nausea and vomiting in CMF or CEF therapy for breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Appetite; Benzimidazoles; Breast Neoplasms; Breast Neoplasms, Male; Cisplatin; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Nausea; Safety; Serotonin Antagonists; Treatment Outcome; Vomiting | 1999 |
[Effects of oral 5-HT3 antagonists on chemotherapy-induced emesis in patients with gynecologic cancers].
Topics: Administration, Oral; Antiemetics; Benzimidazoles; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Genital Neoplasms, Female; Granisetron; Humans; Indoles; Middle Aged; Nausea; Ondansetron; Paclitaxel; Serotonin Antagonists; Tropisetron; Vomiting | 2000 |
Prevention of vomiting after tonsillectomy in children: granisetron versus ramosetron.
Topics: Antiemetics; Benzimidazoles; Child; Child, Preschool; Female; Granisetron; Humans; Infusions, Intravenous; Male; Postoperative Complications; Serotonin Antagonists; Tonsillectomy; Treatment Outcome; Vomiting | 2001 |
Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Appetite; Benzimidazoles; Constipation; Dizziness; Drug-Related Side Effects and Adverse Reactions; Female; Flushing; Gastrointestinal Diseases; Headache; Hematologic Neoplasms; Humans; Indoles; Male; Middle Aged; Nausea; Thirst; Treatment Outcome; Tropisetron; Vomiting | 2001 |
[Nasea injection in the prophylaxis of gastrointestinal reaction induced by chemotherapeutic agents].
Topics: Adolescent; Adult; Aged; Anorexia; Antiemetics; Benzimidazoles; Cisplatin; Digestive System; Female; Granisetron; Humans; Male; Middle Aged; Mitomycin; Nausea; Vomiting | 2000 |
11 other study(ies) available for ramosetron and Emesis
| Article | Year |
|---|---|
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting | 2021 |
Effects of 5-HT
Topics: Acute Kidney Injury; Aged; Animals; Benzimidazoles; Cisplatin; Disease Models, Animal; Female; Granisetron; Humans; Kidney; Male; Mice; Middle Aged; Nausea; Ondansetron; Organic Cation Transport Proteins; Palonosetron; Renal Elimination; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2021 |
Moderate to severe nausea in radioactive iodine (RAI) therapy is associated with the RAI dose per body weight and was not prevented by ramosetron.
Topics: Adenoma; Adult; Aged; Antiemetics; Benzimidazoles; Domperidone; Dose-Response Relationship, Radiation; Female; Fluid Therapy; Humans; Iodine Radioisotopes; Male; Middle Aged; Nausea; Risk Factors; Thyroid Neoplasms; Vomiting | 2014 |
Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Aprepitant; Benzimidazoles; Dexamethasone; Drug Therapy, Combination; Female; Granisetron; Humans; Isoquinolines; Japan; Male; Middle Aged; Morpholines; Neoplasms; Palonosetron; Quinuclidines; Retrospective Studies; Serotonin Antagonists; Vomiting | 2014 |
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer.
Topics: Adult; Aged; Antiemetics; Benzimidazoles; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Female; Fluorouracil; Humans; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Pancreatic Neoplasms; Radiotherapy, Adjuvant; Vomiting | 2009 |
Receptor occupancy theory-based analysis of interindividual differences in antiemetic effects of 5-HT3 receptor antagonists.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Drug Administration Schedule; Granisetron; Humans; Indoles; Models, Theoretical; Ondansetron; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Tropisetron; Vomiting | 2009 |
[Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Granisetron; Humans; Ifosfamide; Male; Middle Aged; Nausea; Ondansetron; Osteosarcoma; Prospective Studies; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2007 |
[Clinical evaluation of antiemetic effects of 5-hydroxytryptamine receptor type 3 (5HT3 receptor) antagonists based on changes in eating condition in cancer patients receiving chemotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bridged Bicyclo Compounds, Heterocyclic; Eating; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms; Oxazines; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2008 |
Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferrets.
Topics: Animals; Benzimidazoles; Biguanides; Cisplatin; Dose-Response Relationship, Drug; Ferrets; Injections, Intravenous; Injections, Intraventricular; Male; Receptors, Serotonin; Serotonin Antagonists; Splanchnic Nerves; Vagotomy; Vagus Nerve; Vomiting | 1993 |
Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
Topics: Animals; Benzimidazoles; Cisplatin; Crystallography, X-Ray; Defecation; Ferrets; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Molecular Conformation; Muscle Contraction; Ondansetron; Rats; Rats, Wistar; Serotonin Antagonists; Structure-Activity Relationship; Vomiting | 1996 |
Antiemetic effects of YM060, a potent and selective serotonin (5HT)3-receptor antagonist, in ferrets and dogs.
Topics: Administration, Oral; Animals; Antiemetics; Apomorphine; Benzimidazoles; Cisplatin; Copper; Copper Sulfate; Cyclophosphamide; Dogs; Female; Ferrets; Injections, Intravenous; Male; Serotonin Antagonists; Stereoisomerism; Vomiting | 1991 |